According to United Therapeutics's latest financial reports the company has a price-to-book ratio of 1.91.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 1.73 | -34.66% |
2022-12-31 | 2.64 | 7.49% |
2021-12-31 | 2.46 | 23.72% |
2020-12-31 | 1.99 | 42.91% |
2019-12-31 | 1.39 | -17.77% |
2018-12-31 | 1.69 | -43.91% |
2017-12-31 | 3.01 | -7.74% |
2016-12-31 | 3.27 | -27.08% |
2015-12-31 | 4.48 | -7.05% |
2014-12-31 | 4.82 | 10.33% |
2013-12-31 | 4.37 | 78.48% |
2012-12-31 | 2.45 | -14.81% |
2011-12-31 | 2.87 | -30.21% |
2010-12-31 | 4.12 | -5.83% |
2009-12-31 | 4.37 | 67.09% |
2008-12-31 | 2.62 | -64.38% |
2007-12-31 | 7.34 | 28.71% |
2006-12-31 | 5.71 | -2.6% |
2005-12-31 | 5.86 | 10.87% |
2004-12-31 | 5.28 | 81.27% |
2003-12-31 | 2.92 | 43.21% |
2002-12-31 | 2.04 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Pfizer PFE | 1.76 | -7.90% | ๐บ๐ธ USA |
Eli Lilly LLY | 68.1 | 3,460.41% | ๐บ๐ธ USA |
Baxter BAX | 2.56 | 33.84% | ๐บ๐ธ USA |
Gilead Sciences GILD | 4.00 | 109.02% | ๐บ๐ธ USA |
Cardinal Health CAH | -7.94 | -515.16% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | 5.39 | 181.90% | ๐ฌ๐ง UK |
Cytokinetics
CYTK | -19.0 | -1,095.38% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | 1.99 | 4.07% | ๐ฎ๐ฑ Israel |